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Abstract 
Purpose: To investigate the hypoglycaemic activity of various extracts of the aerial part of Acalypha 
fruticosa in normal rabbits. 
Methods: The rabbits were randomly assigned to 8 groups (n = 3) and treated with a single oral dose. 
Group 1 served as normal control and received 2 % dimethyl sulfoxide (DMSO, 3 ml/kg); group 2 served 
as standard treatment and received metformin (300 mg/kg); groups 3 - 8 received different extracts of 
Acalypha fruticosa at a dose of (600 mg/kg) as follows: group 3, total methanol extract; group 4, 
Petroleum ether (PET) extract; group 5, chloroform extract; group 6, ethyl acetate extract; group 7, n-
butanol  extract; and group 8, aqueous extract. Serum glucose (fasting blood glucose, FBG) was 
determined using a diagnostic kit on a glucose analyzer. 
Results: A single dose of the aqueous extract of Acalypha fruticosa significantly lowered (p < 0.5) FBG 
at 1, 2, 4, and 6 h by 16, 29.5, 19.8, and 23.9 %, respectively, compared with normal control group, 
whereas standard treatment (metformin) did not affect FBG at all of these time-points measured. 
Furthermore, the aqueous extract (AEA) lowered FBG at 1, 2, 4, and 6 h by 24, 34.4, 25.9, and 17 %, 
respectively (p < 0.5), compared with metformin treatment. Chloroform extract also significantly lowered 
FBG at 1, 2, and 4 h by 17.3, 24.8, and 14.7 %, respectively, compared to metformin treatment (p < 
0.5). 
Conclusion: The results of this study show that the aqueous extract of the aerial parts of Acalypha 
fruticosa possess potential hypoglycaemic activity but further studies are required to elucidate the exact 
mechanisms of action. 
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Diabetes mellitus is a chronic metabolic disease 
with life threatening complications, characterized 
by hyperglycaemia and alterations in 
carbohydrate, lipid and protein metabolism, 
associated with absolute or relative deficiencies 
in insulin secretion and/or insulin action. The 
International Diabetes Federation (IDF) 
estimates that 285 million people, 6.4 % of the 
world population, suffered from diabetes in 2010 
and this prevalence will increase to 439 million 
people, 7.7 % of the world population by 2030 
[1]. 
 
The treatment of hyperglycaemia in diabetic 
patients is directed towards achieving 
euglycemia and minimizes chronic complications 
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by administering oral hypoglycaemic agents. 
Over 400 plants as well as 700 recipes and 
compounds have been scientifically evaluated for 
Type 2 DM treatment [2]. Metformin was 
developed based on a biguanide compound from 
the anti-diabetic herb, French lilac, and is now a 
first line drug for Type 2 DM [3]. Thus Searching 
for new anti-diabetic drugs from natural plants is 
still attractive because they contain substances 
which demonstrate alternative and safe effects 
on diabetes mellitus [4,5]. Medicinal herbs 
contain diverse bioactive compounds 
(glycosides, alkaloids, terpenoids, flavonoids, 
carotenoids, etc.) and can have multiple actions 
on insulin action, insulin production, or both. 
 
Acalypha fruticosa Forssk belongs to the family 
Euphorbiaceae, commonly known as ‘Birch – 
leaved Acalypha’ and it occurs widely in East and 
southern Africa, tropical Arabia, southern India, 
Sri Lanka and Myanmar [6]. It is a strong 
aromatic bushy shrub traditionally used, in 
Ayurvedic and African folk medicine, to treat 
cholera, sexually transmitted diseases, 
dyspepsia, stomach ache, skin diseases, wounds 
and poisonous bites [7-10]. In Yemen, leaf and 
stem have been used to treat skin diseases, 
malaria and wound [11]. In North Kenya, the root 
and the leaves are used to treat liver disorders 
[6]. Several pharmacological studies have 
revealed its antiepileptic [12], antioxidant [13,14], 
anti-bacterial [15], anti-inflammatory [16], anti-
tumor [17], wound healing [18] and cytotoxic 
properties [13]. Qualitative analysis of 
phytochemicals of the various extracts of the 
aerial parts of Acalypha fruticosa indicated the 
presence of triterpenoids, steroids, saponins, 
tannins, phenols, flavonoids, alkaloids, 
anthraquinones and sugars. Quantitative 
estimation of these phyto-constituents showed 
that flavonoids were present in high amount 
when compared to alkaloids, tannins, phenols 
and steroids [19]. 
 
An earlier study showed that the chloroform and 
n-hexane extracts of Acalypha indica, at different 
concentrations, possessed dose dependent α-
amylase inhibition against porcine pancreatic 
amylase [20]. Moreover, the ethanolic extract of 
Acalypha indica was reported to lower blood 
glucose level in STZ-Nicotinamide induced 
diabetic rats when compared to standard 
glibenclamide [21]. Therefore, the present study 
was aimed to investigate the potential 
hypoglycaemic activity of different polarity 
fractions obtained by extracting the aerial part of 
Acalypha fruticosa as well as its acute toxicity. 
To the best of our knowledge, this is the first 
scientific study conducted to assess the in vivo 





The aerial part of Acalypha fruticosa was 
collected from Al-Mahweet area, Yemen 
(November - December 2012). The taxonomy 
and identification of the plant was confirmed by 
Dr. A. Al-Ajami, Department of Botany, Faculty of 
Science, Dhamar University, Yemen. A voucher 
specimen was deposited at the herbarium of 
Department of Pharmacognosy, Faculty of 
Pharmacy, Sana’a University (voucher no. 115).  
 
Extraction and fractionation of Acalypha 
fruticosa 
 
Following collection, the aerial parts of the plant 
were left to dry outside under sunlight. The air 
dried powdered plant (1 kg) was extracted with 
85 % methanol by cold maceration, till 
exhaustion. The combined methanolic extract 
was dried using rotary evaporator to give a dark 
crude residue (130 g) (MEA), from which 120 g 
were suspended in water and subsequently 
extracted with petroleum ether, chloroform, ethyl 
acetate and n-butanol. Each fraction was dried 
over anhydrous sodium sulphate and evaporated 
to dryness to yield fractions PEA (petroleum 
ether, 19 g) CEA (chloroform, 30 g), fraction EEA 
(ethyl acetate, 9.6 g), fraction BEA (n-butanol, 19 
g) and fraction AEA (remaining aqueous mother 
liquor, 41 g). 
 
Preliminary phytochemical screening 
 
A preliminary phytochemical analysis of the 
Acalypha fruticosa extracts was carried out using 
thin layer chromatography (TLC) plates coated 
with silica gel 60 F254 for TLC. The mobile 
phase ethyl acetate: methanol: water (30:5:4) 
was used. Micro-drops of the concentrated 
solutions of the fractions obtained (methanol, 
petroleum ether, chloroform, ethyl acetate, n-
butanol and aqueous extracts) were spotted on 
pre-coated Silica gel plates. The chromatogram 
after complete development was air dried and 
visualized with different chemical reagents to 
detect the presence of flavonoids, phenols, 
tannins, alkaloids, steroids, amino acids, 





Rabbits with an average weight of 1000 g were 
used for the hypoglycaemic activity study and 
Swiss Wistar albino mice with an average weight 
of 25 g were used for the acute toxicity study. All 
animals were fed with standard animal feed and 
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water. Animals were acclimatized to the 
laboratory conditions for 3 weeks prior to 
experimentation. All experiments carried out 
were approved by the Institutional Ethical 
Committee, Faculty of Medicine and Health 
Sciences, Sana`a University (790-15/02/2013) 
and were conducted according to the standard 
guideline for the use of laboratory animals [22]. 
 
Acute toxicity study 
 
Six mice were used and randomly assigned to 
control or treatment group (n = 3). The animals 
were deprived of food but given water 16 h prior 
to dosing. The methanol extract (5 g/kg) were 
then given orally to test group, while the control 
group received water at the same volume. Body 
weight, signs of toxicity (changes in skin and fur, 
eyes and mucus membrane, behavioral pattern 
including: tremors, convulsions, salivation, 
diarrhea, lethargy, sleep, coma) and mortality 
were observed after administration at the third 
hour on the first day, and throughout the 
following 48 h and then daily thereafter for 14 
days. 
 
Determination of hypoglcaemic activity 
 
For determination of the hypoglycaemic activity 
of Acalypha fruticosa, 24 rabbits (600 - 1000 g) 
were used and randomly assigned to 8 groups (3 
animals per group). All rabbits were treated orally 
with a single dose. Group 1 served as normal 
control group and received distilled water and 2 
% DMSO; group 2 served as standard treated 
with metformin (300 mg/kg) suspended in 
DMSO; groups 3 - 8 received different extracts of 
Acalypha fruticosa at a dose of (600 mg/kg) 
suspended in DMSO as follows: group 3 
received methanolic extract; group 4 received n-
butanol extract; group 5 received petroleum ether 
extract; group 6 received ethyl acetate extract; 
group 7 received chloroform extract; and group 8 
received aqueous extract. Blood samples were 
collected, from the ear vein just prior to (0 hour) 
and at 1, 2, 4, 6 and 12 hours after dosing for 
acute study, into plain dry tubes and centrifuged 





The serum samples obtained were transferred 
into Eppendorf tubes and analyzed by Cobas C 
311 analyzer (Roche Diagnostics - GmbH, D-
68298 Mannheim, Germany) for serum glucose 
using a commercially available kit (Roche 




Statistical analysis was performed using Social 
Package of Social Sciences (SPSS) version 11.5 
(SPSS Inc, Chicago, IL, USA). The results are 
presented as mean ± standard deviation (SD). 
The data were analyzed by one-way analysis of 
variance (ANOVA) followed by Duncan's test to 
compare the groups. A value of p < 0.05 was 




Preliminary phytochemical examination of the 
different fractions (Table 1) revealed the 
presence of phenolic compounds in all the 
extracts, whereas flavonoids and amino acids 
were detected in methanol, chloroform, ethyl 
acetate, n-butanol and aqueous extracts of 
Acalypha fruticosa. Alkaloids were detected in 
the methanol and n-butanol extracts, while 
triterpenes glycosides were found in all extracts 
except the aqueous extract. Persistent foaming 
was observed for all the extracts, suggesting the 
presence of saponins. 
 
Table 1: Phytochemical profile of aerial parts of Acalypha fruticosa 
 
Phyto-constituent Test Extract 
MEA PEA CEA EEA BEA AEA 
Flavonoids KOH + - + + + + 
AlCl3 + - + + + + 
Phenols 
+ tannins 
FeCl3 + + + + + + 
NH3 Vapour + + + + - - 
Alkaloids Dragendorff's 
Reagent 
+ - - - + - 
Amino acids+proteins Xanthoproteic test + - + + + + 
Steroids and 
Triterpene glycosides 
Liebermann - Burchard's test + + + + + - 
MEA, methanol; PEA, petroleum ether; CEA, Chloroform; EEA, ethyl acetate; BEA, n-butanol; AEA, aqueous 
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There were no toxic symptoms or mortality 
observed in any animals, which lived up to 14 
days, following the administration of the 
methanol extract of the aerial parts of Acalypha 
fruticosa at a single dose level of 5 g/kg body 
weight. Moreover, the observed behavioral 
changes and toxicological signs (Table 2) 
showed no obvious differences between the 
treated and control animals. The general 
appearance of animals was normal (skin & fur, 
eyes and mucous membrane). The behavioral 
patterns of animals as well as breathing were 
also normal with no disturbance in food intake, 
water consumption or sleep. 
 
Table 3 shows the hypoglycaemic activity of a 
single dose of the various extracts of Acalypha 
fruticosa. On comparing the level of FBG of the 
animals treated with either metformin (300 
mg/kg) or the various extracts of Acalypha 
fruticosa (600 mg/kg) with that of the normal 
control animals showed that metformin did not 
affect FBG levels at all the time-points measured. 
On the other hand, the aqueous extract 
significantly lowered (p < 0.5) FBG at 1, 2, 4, and 
6 hours by 16, 29.5, 19.8, and 23.9 %, 
respectively. However, chloroform extract 
significantly lowered (p < 0.5) FBG at 1 and 4 
hours by 8.5 and 7.8 %. In contrast, ethyl acetate 
extract raised FBG significantly (p < 0.5) by 21.6 
% at 1 h and no significant effect at other time 
points. On the other hand, on comparing the 
level of FBG of the animals treated with the 
various extracts of Acalypha fruticosa with that of 
the animals treated with metformin showed that 
the aqueous extract lowered FBG at 1, 2, 4, and 
6 h by 24, 34.4, 25.9 and 17 %, respectively. 
Chloroform extract significantly lowered (p < 0.5) 
FBG at 1, 2 and 4 h by 17.3, 24.8, and 14.7 %, 
respectively, whereas the methanol extract 
significantly lowered (p < 0.5) FBG at 1 and 4 h 
by 13.2 and 16.8 %. In contrast, petroleum ether 
extract significantly lowered FBG by 17.2 % at 4 




Traditional plant medicines are used throughout 
the world for a range of diabetic presentations. In 
light of this we made an attempt for the first time 
to study the effect of Acalypha fruticosa in 
normoglycaemic rabbits. 
 






0.5 h 24 h 48 h 2 weeks 
Skin & Fur N N N N N 
Eyes N N N N N 
Mucous membrane N N N N N 
Behavioral pattern N N N N N 
Breathing  N N N N N 
Tremors N.Oa N.Oa N.Oa N.Oa N.Oa 
Salivation N.Oa N N N N 
Diarrhea N.Oa N.Oa N.Oa N.Oa N.Oa 
Lethargy N.Oa N.Oa N.Oa N.Oa N.Oa 
Sleep N.Oa N N N N 
Coma N.Oa N.Oa N.Oa N.Oa N.Oa 
N = normal; a not observed 
 
Table 3: Effect of a single dose of Acalypha fruticosa extracts on fasting blood glucose of normal rabbits 
 
Groups Fasting blood glucose (mg/dl) 
0 1 h 2 h 4 h 6 h 12 h 
Control 100 ± 3.4bc 94 ± 2.3edc 94 ± 1.7bac 99 ± 1.7ba 96.3 ± 0.3bac 106 ± 12.7a 
Metformin 111.3 ± 2ba 104 ± 2.8bac 101 ± 4.6ba 107 ± 4a 88.3 ± 2.6bc 90.3 ± 2a 
MEA 123.3 ± 2.6a 90.3 ± 0.8edf 90.3 ± 7.2bc 89 ± 2.3bc 86 ± 2.8c 89..3 ± 0.3a 
PEA 102.3 ± 4.3bc 101.6 ± 3.2bdc 97 ± 7.7ba 88.6 ± 12.7bc 106 ± 2a 94.6 ± 7.6a 
CEA 105.3 ± 8.3bc 86 ± 0.5ef 76 ± 2.3dc 91.3 ± 4.9dc 99 ± 2.8ba 98.3 ± 3.1a 
EEA 108.3 ± 6b 114.3 ± 2a 95 ± 1.7bac 92 ± 4.3bac 100.3 ± 0.3ba 94 ± 6.3a 
BEA 112 ± 4.5a 106 ± 2.8ba 110.3 ± 3.4a 94.6 ± 2bac 93.6 ± 3.3bac 97 ± 4.7a 
AEA 93.3 ± 2c 79 ± 8f 66.3 ± 11.8d 79.3 ± 6.6c 73.3 ± 8.9d 95.3 ± 4.3a 
Values with same letter are not significant, whereas values with different letters are significant p < 0.5; MEA, 
methanol; PEA, petroleum ether; CEA, Chloroform; EEA, ethyl acetate; BEA, n-butanol; AEA, aqueous 
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In this study, a single dose of the aqueous 
extract (600 mg/kg) of Acalypha fruticosa 
significantly lowered the FBG with respect to 
both the control (16 - 24 %) and the metformin 
treated group (17 - 34 %). This observed 
potential hypoglycaemic activity might be due to 
the reported occurrence of flavonoids in 
Acalypha fruticosa [19]. Previous investigations 
have demonstrated a promising role for 
flavonoids as anti-diabetic agents [23,24]. 
Flavonoids such as kampferol and quercetin 
have been reported to affect the pancreatic β-
cells leading to their proliferation and secretion of 
more insulin [25,26]. The long-term consumption 
of quercetin appears to control blood glucose 
levels in streptozotocin (STZ)-induced diabetic 
animals [27,28]; and has also been suggested 
that quercetin protects the pancreas against 
oxidative stress in STZ-treated animals, 
improving hyperglycemia [29,30]. A recent study 
revealed that the blood glucose lowering activity 
of flavonoid compounds: boswellic acid, ellagic 
acid, quercetin, and rutin may be by stimulating 
β-cells to release more insulin [31]; and 
suggested that the pronounced activity of these 
compounds could be because of enhanced 
peripheral glucose utilization by skeletal muscle 
in addition to that of β-cell stimulation. In 
addition, quercetin has been reported to inhibit α-
glucosidase activity in vitro [32,33]; and its use 
on glucose absorption in obesity, and obesity 
with type 2 diabetes patients on oral glucose 
tolerance test has been investigated [34]. 
 
Additionally, the observed hypoglycaemic effect 
might be the result of the presence of minerals in 
Acalypha fruticosa. Quantitative estimation of 
minerals in the dried powder of its aerial part 
showed the concentration of macro-elements (K, 
Na, Ca, Mg and S) to range from 0.01 - 4.23 %, 
with calcium being present in high amount 
followed by magnesium and potassium, and that 
of the micro-elements (Zn, Cu, Fe, Mn, Bo and 
Mo) from 0.02 - 87.62 ppm with iron and 
manganese being present in higher 
concentrations [19]. Microelements as cofactors 
of enzymes play a vital role in improving glucose 
metabolism and increasing insulin sensitivity [35]. 
Manganese has been reported to improve 
glucose metabolism, and its deficiency may 
interrupt the insulin secretion process and 
increases insulin resistance. Potassium has also 




The results presented in this study show that the 
aqueous extract of the aerial part of Acalypha 
fruticosa possesses hypoglycaemic activity in 
normal rabbits, and thus has potentials for 
development into therapeutic agents for the 
treatment of diabetes mellitus. However, further 
studies are required for the isolation and 
structural elucidation of the active component(s) 
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